Background: Studies have shown that depression relates to biomarkers of both short-and long-term polyunsaturated fatty acid (PUFA) intake. However, it is not known which of these two biomarkers has the closest relationship to depression. Objective: To examine the relationship of depression with both adipose tissue and serum cholesteryl ester PUFA and to assess the importance of each of these two biomarkers in relating to depression. Design: Cross-sectional study of healthy elderly men from the island of Crete. Setting: The Preventive Medicine and Nutrition Clinic, University of Crete, Greece. Subjects: A total of 150 males, aged 80-96 years. The subjects were survivors of the Greek Seven Countries Study group. Methods: Fatty acids were determined by gas chromatography in adipose tissue and serum cholesteryl esters. Information about depression was obtained through the use of the short form of the Geriatric Depression Scale (GDS-15). Results: Regression analysis showed that depression related positively to age and serum cholesteryl ester arachidonic/ docosahexaenoic fatty acid ratio. The only significant unadjusted correlation between depression and serum cholesteryl ester and adipose fatty acids was with adipose alpha-linolenic acid (ALA) (r ¼ À0.31, Po0.01). Depressed males (GDS-1545) had lower adipose ALA and sum n-3 fatty acids than non-depressed ones. There were no significant differences between depressed and non-depressed males in serum cholesteryl ester fatty acids. When adipose tissue ALA was included as one of the independent measures in the regression model, the observed positive relation between GDS-15 depression and cholesteryl ester arachidonic/docosahexaenoic ratio failed to persist. Instead, there was a negative relationship between GDS-15 depression and adipose tissue ALA.
Introduction
Epidemiological studies have shown that increased consumption of fish is associated with decreases in depression prevalence (Nakane et al., 1988; Hibbeln, 1998; Tanskanen et al., 2001) . There are indications, that depletions in docosahexaenoic acid (C22:6n-3) (DHA) and other longchain n-3 polyunsaturated fatty acids (PUFA) may be associated with depression. Lower proportions of long-chain n-3 PUFA have been reported in the plasma, red blood cell membranes and serum cholesteryl esters and phospholipids of depressed patients as opposed to healthy controls (Adams et al., 1996; Maes et al., 1996 Maes et al., , 1999 Edwards et al., 1998; Peet et al., 1998) . However, not only n-3 polyunsaturates, but also PUFA of the n-6 family were implicated in depression. Elevated n-6/n-3 PUFA and arachidonic (C20:4n-6) to eicosapentaenoic acid (C20:5n-3) ratios have been observed in erythocytes and serum cholesteryl esters and phospholipids of depressed patients as opposed to healthy controls (Adams et al., 1996; Maes et al., 1996 Maes et al., , 1999 . Nevertheless, given that plasma and serum phospholipids and cholesteryl esters reflect fatty acid intake over a few-day to few-week period (Glatzz et al., 1989; Katan et al., 1997) , the decreased n-3 PUFA in depression reported by the bulk of the studies, appears to reflect, in part, a corresponding reduced consumption in the particular fatty acids. Three studies have examined the relation of depression and long-term n-3 PUFA intake (Mamalakis et al., 2002 (Mamalakis et al., , 2004 (Mamalakis et al., , 2004a . The adipose tissue composition is a biomarker of long-term or habitual dietary fat intake (1-3 years) (Dayton et al., 1966; Beynen et al., 1980) . Two of the three studies examining the relationship between adipose tissue PUFA and depression reported negative relations between n-3 PUFA and depression (Mamalakis et al., 2002 (Mamalakis et al., , 2004 .
The studies on depression and serum phospholipid and cholesteryl ester and adipose tissue fatty acids indicate that depression relates to both short-term as well as long-term PUFA intake. However, it is not known which of these biomarkers bare the strongest relation with depression and are thus more reliable indicators of the true relation between depression and PUFA intake. It is not known whether longterm PUFA intake is a better predictor of depression than short-term intake, or vice versa. No studies have as yet examined the relationship of depression with both serum cholesteryl ester and adipose tissue fatty acids simultaneously.
The purpose of the present study is to examine the relationship of depression with both adipose tissue and serum cholesteryl ester PUFA and to assess the relative importance of each of these two biomarkers in predicting depression.
Methods

Subjects
The study sample consisted of 150 elderly males from the island of Crete. The subjects were survivors of the Greek Seven Countries Study group, the year 2000. Subjects were living in their own homes and were self-reliant (e.g. able to prepare their own food). Subjects came from rural communities and were involved in small farming business. Depression assessments (GDS-15) were made on 124 subjects. Subjects were between 80 and 96 years of age. The mean age was 84 years, while most of the subjects (72%) were between 80 and 85 years of age. Seventy-eight subjects consented to provide adipose tissue biopsy samples. Serum cholesteryl ester fatty acid measures were obtained from 127 subjects. All subjects were informed about the nature and the purpose of this study and signed a consent form. The ethical committee at the University of Crete had previously approved the protocol of this research. Subjects were examined by the Preventive Medicine and Nutrition Clinic of the University of Crete. This is the second study on depression and PUFA in the particular elderly group (Mamalakis et al., 2004) . The difference between this study from the previous one lies in that serum cholesteryl ester fatty acid measures had not been included in the statistical analysis in the previous study.
Depression assessment
Depression level was assessed through the use of a Greek translation of the short form of the Geriatric Depression Scale (GDS-15). (GDS-15), a 15-item scale, has been reported to constitute a valid and reliable depression measure (Sheikh and Yesavage, 1986; Almeida and Almeida, 1999; Fountoulakis et al., 1999) . Geriatric Depression Scale has been standardized in elderly Greeks (Fountoulakis et al., 1999) .
Anthropometric measures
Body weight was assayed by a digital scale (Seca) with an accuracy of 7100 g. Subjects were weighed without shoes, in their underwear. Standing height was measured without shoes to the nearest 0.5 cm with the use of a commercial stadiometer with the shoulders in relaxed position and arms hanging freely. Body mass index (BMI) was calculated by dividing weight (kg) by height squared (m 2 ).
Adipose tissue measures
Buttock subcutaneous tissue samples were collected by aspiration, using the method described by Beynen and Katan (1985) . The particular method has been reported to be rapid and safe, and to cause no more discomfort than a routine venipuncture (Beynen and Katan, 1985) . Buttock adipose tissue samples can be safely stored for up to 1.5 years without changes in the component fatty acids (Beynen and Katan, 1985) . Samples were taken from the left upper outer quadrant of the gluteal area, through the use of a 10 ml vaccutaneous tube. Prior to aspiration, aspiration sites were sprayed with local anesthetic (ethyl chloride). Adipose tissue samples were stored in À801C. Prior to analysis samples were thawed and the fat was transferred to 10 ml screw-capped tubes with the aid of Pasteur pipettes and several drops (B0.5 ml) of chloroform:methanol (2:1, v/v). Methyl esters of the fat component fatty acids were prepared in the screwcapped vials according to the method described by Metcalfe et al. (1966) . Briefly, 20-30 mg of fat sample were saponified with 1.0 ml NaOH in methanol and the fatty acid methyl esters (FAME) were prepared with 14% boron trifluoride in methanol following extraction with hexane after washing with saturated NaCl. The hexane (upper layer) containing the FAME was transferred to GC vials and stored at À201C until analysis. The FAME were separated on a 100 Â 0.25 mm 2 Id.SP-2560 fused silica capillary column, coated with a 0.25 mm of cyanopropyl silicone provided by SUPELCO, using a SHIMADZU GC-17A/FID gas chromatograph equipped with an AOC-20I auto injector. The Class-VP chemstation software was used for quantitation and identification of peaks. Baseline separation of over 50 FAME peaks was accomplished by means of mixed FAME standards (Sigma). The analytical conditions employed were as follows: volume injected 1 ml, carrier gas helium (1.1 ml/min), injector temperature 2501C, FID 2601C, split ratio 1:4-1:20 (depending on the sample quantity), and oven temperature from 140 to 2451C with stepped temperature program: within total run time 54 min. The fatty acids have been expressed as percent of the total fatty acids present in the chromatogram.
Serum cholesteryl ester fatty acid measures Serum (200 ml) was deproteinated with a mixture of chloroform/methanol (1/1) and the precipitate was removed by centrifugation. After addition of 750 ml of water, the chloroform layer was transferred into another tube and the solvent was removed by evaporation. The dry lipid fraction was dissolved in a small volume of chloroform and applied onto an aminopropyl solid-phase column (Bond-Elut NH 2 200 mg, Varian Ass.). The cholesteryl-bound fatty acids were eluted with hexane. The free fatty acids, triglycerides and phospholipids remained bound to the column. The hexane was removed by evaporation under nitrogen. Then the cholesteryl-fatty acid esters were hydrolyzed and methylated simultaneously with a mixture of 100 ml toluene and 0.5 ml BF 3 /MeOH for 60 min at 1001C in a heating block. After cooling, 800 ml destilled water and 800 ml hexane were added. After shaking and settling, the hexane layer (upper layer) containing the FAME was transferred to GC vials and stored at À201C until analysis. The FAME were separated on a 100 Â 0.25 mm 2 ID WCOT fused silica capillary column, coated with a 0.25 mm of CP-Slect CB provided by Varisn Ass., Middelburg, The Netherlands using a Varian Ass. GC-3900 gas chromatograph equipped with an CP 8400 auto injector. The Galaxie software was used for quantitation and identification of peaks. Baseline separation of over 50 FAME peaks was accomplished by means of mixed FAME standards (Sigma). The analytical conditions employed were as follows: volume injected 1 ml, carrier gas nitrogen (1.1 ml/min), injector temperature 2501C, FID 2751C, split ratio 1:20 and oven temperature from 185 to 2451C with stepped temperature program: within total run time 57 min. The fatty acids have been expressed as percent of the total fatty acids present in the chromatogram.
Statistical methods
Data were analyzed through the use of the SPSS statistical package. The statistical methods used were one-way ANOVA, Spearman's correlations and linear multiple stepwise Regression analysis.
Results Table 1 depicts means and s.d. of serum cholesteryl ester and adipose tissue fatty acids for the subjects that consented to provide adipose tissue biopsy samples (n ¼ 78) and for which there were serum cholesteryl ester fatty acid measures (n ¼ 127). Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids G Mamalakis et al
Spearman's correlation analysis on the subjects with complete data on both serum cholesteryl ester and adipose tissue fatty acids indicated that shorter-chain serum cholesteryl ester PUFA such as C18:2n-6, C18:3n-6 and C18:3n-3 did not correlate significantly with the respective PUFA of the adipose tissue. However, longer-chain serum cholesteryl ester PUFA correlated significantly with the respective PUFA of the adipose tissue. Specifically, the correlations between serum cholesteryl ester C20:3n-6, C20:4n-6, C20:5n-3 and C22:6n-3 with the respective fatty acids of the adipose tissue were (r ¼ þ 0.41, Po0.001), (r ¼ þ 0.32, Po0.01), (r ¼ þ 0.46, Po0.001) and (r ¼ þ 0.47, Po0.001), respectively. Serum cholesteryl ester C20:4n-6/C22:6n-3 ratio correlated with that of the adipose tissue (r ¼ þ 0.57, Po0.0005). In addition, serum cholesteryl ester sum n-3 PUFA correlated with those of the adipose tissue (r ¼ þ 0.29, Po0.05). Saturated adipose tissue C14:0 and C16:0 correlated significantly with the respective fatty acids of serum cholesteryl esters (r ¼ þ 0.57, Po0.0005) and (r ¼ þ 0.40, Po0.0005), respectively. Adipose C18:0 did not correlate significantly with the respective serum cholesteryl ester fatty acid. Sum saturated adipose tissue fatty acids correlated significantly with the respective fatty acids of serum cholesteryl esters (r ¼ þ 0.42, Po0.0005). Of the monounsaturated fatty acids, adipose C14:1 and C18:1 correlated significantly with the respective fatty acids of serum cholesteryl esters (r ¼ þ 0.28, Po0.02) and (r ¼ þ 0.39, Po0.0005) respectively. Adipose C16:1 and sum adipose monounsaturated fatty acids did not correlate significantly with the respective serum cholesteryl ester fatty acids.
There was only one significant correlation between an individual fatty acid or a class of fatty acids to depression, namely a negative correlation to adipose tissue C18:3n-3 (alpha-linolenic acid) (r ¼ À0.31, Po0.01) (Figure 1) . Table 2 depicts means and s.d. for the serum cholesteryl ester and adipose tissue PUFA in depressed vs non-depressed subjects. Depressed subjects were older than their nondepressed counterpart (Po0.001). Depressed subjects had significantly lower adipose tissue alpha-linolenic acid (C18:3n-3) than the non-depressed subjects (Po0.02) and this was also reflected in a lower sum of adipose n-3 fatty acids (Po0.04). There were no significant differences between the two groups in any other individual fatty acid or groups of fatty acids.
A multiple linear regression using age, BMI and individual serum cholesteryl ester fatty acids and classes of serum cholesteryl ester fatty acids as independent variables returned a highly significant correlation of depression to age (B ¼ 0.29, t ¼ 3.0, Po0.003), no correlation to BMI or any individual serum cholesteryl ester fatty acid or classes of fatty acids, and a significant correlation to serum cholesteryl ester C20:4n-6/C22:6n-3 ratio (B ¼ 0.20, t ¼ 2.1, Po0.04). Together, age and serum cholesteryl ester C20:4n-6/C22:6n-3 ratio significantly accounted for 13% of the variability in GDS-15 depression (F ¼ 7.7, Po0.001). As shown by beta coefficients, age is the major predictor of GDS-15 depression followed by serum cholesteryl ester C20:4n-6/C22:6n-3 ratio.
In a subsequent regression model, when adipose tissue C18:3n-3 was also included as one of the independent measures already present in the former regression model, the significant relations of depression to age and cholesteryl ester C20:4n-6/C22:6n-3 ratio failed to persist. Instead, a significant relation between depression and adipose tissue C18:3n-3 emerged. Specifically, 8% of the variability in GDS-15 depression was significantly accounted for by adipose tissue C18:3n-3 (F ¼ 6.8, Po0.01). Beta coefficient shows that adipose tissue C18:3n-3 related negatively to depression (B ¼ À0.31, t ¼ À2.6, Po0.01).
Discussion
It appears that the survivors of the Greek Seven Countries Study group are more depressed than other elderly groups of the same age. For example, 24% of the elderly sample of the Leiden 85-plus study were depressed (GDS-15X4) (Vinkers et al., 2004) . By contrast, 51.6% of the survivors of the Greek Seven Countries Study group were depressed (GDS-15X4). Also, in a representative study of 14217 people aged 75 years and over in the UK, 7.7% of the 80-84-year-age group were depressed (GDS-15X6) (Osborn et al., 2003) . The corresponding proportion of depression (GDS-15X6) in the surviving sample of the Greek Seven Countries Study group was 37.9%.
The positive relationship between serum cholesteryl ester C20:4n-6/C22:6n-3 ratio and depression may reflect the opposing effects of C20:4n-6 (AA) and DHA on prostaglandin E-2 (PGE 2 ) production. AA is the immediate precursor of PGE 2 (Krakauer et al., 1986) . On the other hand, DHA inhibits the formation of PGE 2 (Lokesh and Kinsella, 1987; Kelley et al., 1999; Colin et al., 2003) . It has been proposed that elevated levels of PGE 2 are implicated in depression (Lieb et al., 1983; Linnoila et al., 1983; Calabrese et al., 1986 Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids G Mamalakis et al Ohishi et al., 1988; Nishino et al., 1989; Colin et al., 2003; Myint and Kim 2003; Muller et al., 2004) . Therefore, the elevated serum cholesteryl ester C20:4n-6/C22:6n-3 ratio with increasing depression, in the present study, may be mediated by increases in PGE 2 levels. Unlike other studies that reported reduced levels of EPA in depression, the present study failed to observe a significant inverse relationship between depression and the particular fatty acid (Maes et al., 1996 (Maes et al., , 1999 . Also, this study failed to demonstrate the positive relationships between depression and AA/EPA ratios or sum n-6/sum n-3 PUFA ratios reported by others (Adams et al., 1996; Maes et al., 1996 Maes et al., , 1999 . This is the first literature report of a relationship between AA/DHA ratio and depression. Clearly, our finding needs to be replicated by other studies.
Another reason for the observed positive relationship between serum cholesteryl ester C20:4n-6/C22:6n-3 ratio and depression may relate to the reported opposing effects of AA and DHA on neuron integrity in the hippocampus. One of the pathophysiological features of depression is neuronal atrophy and volume loss in the hippocampus (Sheline et al., 1999; Sapolsky, 2000) . Animal studies have indicated that n-3 PUFA, including DHA, exert neuroprotective effects in the hippocampus (Ikemoto et al., 2000; Ahmad et al., 2002; Wang et al., 2003) , whereas AA and its cyclooxygenase and lipogygenase metabolites exert opposite effects (Himmelseher et al., 1996; Paoletti et al., 1998; Kim et al., 2000; Shanker et al., 2004) .
The results of this study appear to indicate that adipose fatty acids are stronger predictors of depression than serum cholesteryl ester fatty acids. For example, unlike adipose fatty acids, there were no significant unadjusted correlations between cholesteryl ester fatty acids and depression. Furthermore, although there were significant differences between depressed and non-depressed males in adipose fatty acids, no such differences manifested for cholesteryl ester fatty acids (Table 2) . Finally, regression analysis showed that the observed positive relation between GDS-15 depression and cholesteryl ester C20:4n-6/C22:6n-3 ratio failed to persist when adipose tissue C18:3n-3 was included as the one in the independent measures in the regression model. Instead, a significant relation emerged between GDS-15 depression and adipose tissue C18:3n-3. There were two reasons for including the particular fatty acid as one of the independent variables. One reason is the observed significant correlation between GDS-15 and this fatty acid. The other reason is that a previous study of this elderly group had indicated a significant inverse relationship between the particular adipose fatty acid and GDS-15 (Mamalakis et al., 2004) . However, serum cholesteryl ester fatty acid measures had not been included in the statistical analysis at that time (Mamalakis et al., 2004) . The adipose tissue is a biomarker of long term (1-3 years) or habitual dietary fat intake (Dayton et al., 1966; Beynen et al., 1980) . On the other hand, serum cholesteryl esters is a biomarker of fatty acid intake of the preceding 1-2 weeks (Katan et al., 1997) . Based on our findings, it appears that depression is more strongly related to long-term than to short-term fatty acid intake. A possible explanation may relate to the rate of deposition of dietary PUFA to the nervous system. Animal studies have shown that as a result of dietary replacement regimens, there was a relatively slow rate of replacement of long-chain PUFA to the brains of animals previously depleted (dietary restriction/deprivation studies) in the particular fatty acids (Bourre et al., 1987; Connor et al., 1990; Moriguchi et al., 2001) . The speed of recuperation from PUFA depletion was slower in the brain compared to other tissues (Moriguchi et al., 2001) . It has been reported that, in animals, total recovery of brain PUFA takes several weeks to complete (Youyou et al., 1986; Bourre et al., 1987; Homayoun et al., 1988; Connor et al., 1990; Moriguchi et al., 2001) . It is estimated that there is a 0.3% daily replacement rate for arachidonic acid in the human brain (Rapoport et al., 2001) . Based on these observations, it may be reasonable to assume that brain fatty acids reflect long-term rather than shortterm fatty acid intake and are thus more strongly related to adipose tissue than to serum cholesteryl ester fatty acids. However, this assumption has not been tested yet. Nevertheless, relative to serum cholesteryl ester fatty acids, adipose ones may be more strongly related to brain fatty acids and depression, thereto. This is the first study that has investigated both serum cholesteryl ester and adipose tissue fatty acids in relation to depression. The implication of our findings is that relative to biomarkers of short-term fatty acid intake, biomarkers of long-term fatty acid intake is a better index of the true relation between fatty acids and depression. Furthermore, biomarkers of long-term fatty acid intake may provide a better estimate than those of shortterm one, of the true relation between dietary fatty acids and human brain diseases. More studies are needed to confirm our findings. Depression is characterized by elevated cytokines such as IL-1, IL-6 and tumor necrosis factor (TNF)-alpha (Maes et al., 1993; Musselman et al., 2001; Hestad et al., 2003) . On the other hand, human studies have reported reductions in IL-1, IL-6 and TNF-alpha synthesis as a result of dietary supplementation with C18:3n-3 (Caughey et al., 1996; James et al., 2000; Rallidis et al., 2003) . The observed inverse relationship between adipose tissue C18:3n-3 and depression, therefore, may be mediated by decreases in IL-1, IL-6 and TNF-alpha levels. To the best of our knowledge, there are no literature reports that depression is associated with aversion for certain foods (e.g. sea food). Often, depression is associated with diminished appetite, food and caloric intake, and weight loss (Kazes et al., 1994; Antonijevic et al., 1997) . However, this is unlikely to be the case in our depressed sub-sample. The reason is that reduced food and energy intake is accompanied by decreases in BMI and serum cholesteryl ester C18:2n-6, and increases in serum cholesteryl ester C16:0 and C20:4n-6 fatty acids, a fact not evidenced in the depressed sub-sample relative to the non-depressed one (Schouten et al., 1981; Rossner et al., 1989; Phinney et al., 1991) . Furthermore, the fact that the entire sample consisted of farmers, rules out the possibility that the reduced adipose tissue C18:3n-3 levels in our depressed sub-sample have been reflecting socioeconomic differences from the non-depressed one. Finally, there was no health or nutrition education intervention component in the Seven Countries Study. Therefore, it is considered unlikely that the subjects' participation in the Seven Countries Study may have had an influence on their dietary habits. The observed inverse relationship between adipose tissue C18:3n-3 and depression indicates that a reduced long-term C18:3n-3 intake is associated with an elevated risk for depression in the elderly.
In conclusion, the positive relationship between serum cholesteryl ester AA/DHA ratio and depression may reflect the opposing effects of AA and DHA on PGE 2 production. Another reason for the observed positive relationship may be the reported opposing effects of AA and DHA on neuron integrity in the hippocampus. It appears that the fatty acids of the adipose tissue are better predictors of depression than those of serum cholesteryl esters. This indicates that depression relates more strongly to long-term than to short-term fatty acid intake. The reason for this may be the reported slow rate of deposition of dietary PUFA to the brain. The inverse relationship between adipose tissue C18:3n-3 and depression may be mediated by reductions in IL-1, IL-6 and TNF-alpha levels. This inverse relationship indicates that a reduced long-term C18:3n-3 intake is associated with an elevated risk for depression in the elderly.
